Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma.
Craniopharyngioma
Hypopituitarism
Obesity
Perimetry
Visual field
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
19
10
2022
accepted:
24
03
2023
medline:
5
6
2023
pubmed:
12
4
2023
entrez:
11
4
2023
Statut:
ppublish
Résumé
Craniopharyngiomas (CP) are benign tumours of the sellar region. Hypopituitarism, visual deficits, hypothalamic damage with consequent obesity and related increased cardiovascular risk, are complications due to the tumour itself or secondary to treatment strategy. We retrospectively correlated visual field status with clinical, neuroradiological, histopathological features and management strategy, in a single-centre cohort of patients with CP. Thirty-four patients (16 M; median age 27.2 ± 21.8 yrs) with CP were included. We evaluated visual field status, assessed by means of standard automated perimetry and expressed as mean deviation (MD), at last follow-up visit (median 14 ± 11.7 yrs). MD has been correlated with clinical, radiological, histological data and treatment modalities. In univariate analysis worst eye MD was significantly associated with panhypopituitarism (p 0.010). In multivariable linear regression, panhypopituitarism (p 0.008), CP recurrence (p 0.020) and DI (p 0.004) were found to be the main independent predictors of a worse visual field outcome. When stratifying patients according to the degree of visual field impairment (MD < -12 dB Vs MD > -12 dB), the main independent predictors of worse visual field outcome were older age at diagnosis (p 0.010), CP histological subtype (p 0.004), invasiveness (p 0.04), CP recurrence (p 0.035), DI (p 0.002) and weight at last follow-up (p 0.012). In CP patients the long-term ophthalmological impairment is frequent, especially at older age, and strictly related to tumour invasiveness and recurrence, and associated to pituitary disfunction and obesity.
Identifiants
pubmed: 37040006
doi: 10.1007/s12020-023-03359-x
pii: 10.1007/s12020-023-03359-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
50-53Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
A. Poretti, M.A. Grotzer, K. Ribi, E. Schönle, E. Boltshauser, Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev. Med. Child. Neurol. (2004). https://doi.org/10.1017/s0012162204000374
C. Capatina, M. Vintila, I. Gherlan, A. Dumitraşcu, A. Caragheorgheopol, C. Procopiuc, V. Ciubotaru, C. Poiana, Craniopharyngioma—clinical and therapeutic outcome data in mixed cohort of adult and pediatric cases. Acta Endocrinol. (Buchar). (2018). https://doi.org/10.4183/aeb.2018.549
I. Chakrabarti, A.P. Amar, W. Couldwell, W.H. Weiss, Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma. J. Neurosurg. (2005). https://doi.org/10.3171/jns.2005.102.4.0650
M.J. Wan, M. Zapotocky, E. Bouffet, U. Bartels, A.V. Kulkarni, J.M. Drake, Long-term visual outcomes of craniopharyngioma in children. J. Neurooncol. (2018). https://doi.org/10.1007/s11060-018-2762-3
I. Forchheimer, C.G. de Moraes, C.C. Teng, F. Folgar, C. Tello, R. Ritch, J.M. Liebmann, Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye Lond. 25, 626–632 (2011)
doi: 10.1038/eye.2011.33
pubmed: 21394112
pmcid: 3171256
S. Cannavò, F. Marini, F. Trimarchi, Patients with craniopharyngiomas: therapeutical difficulties with growth hormone. J. Endocrinol. Invest 31, 56–60 (2008)
pubmed: 19020388
S. Kopparapu, A.M. Khalafallah, D. Botros, A.R. Carey, F.J. Rodriguez, D. Duan, N.R. Rowan, D. Mukherjee, Predictors of postoperative visual outcome after surgical intervention for craniopharyngiomas. World. Neurosurg. (2021). https://doi.org/10.1016/j.wneu.2021.01.044
F. Ferraù, F. Spagnolo, O.R., Cotta, L. Cannavò, A. Alibrandi, G. Russo, T. Aversa, F. Trimarchi, S. Cannavò, Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma. Endocrine (2017). https://doi.org/10.1007/s12020-016-1196-y
P. Dogra, L. Bedatsova, J.J. Van Gompel, C. Giannini, D.M. Donegan, D. Erickson. Long-term outcomes in patients with adult-onset craniopharyngioma. Endocrine (2022). https://doi.org/10.1007/s12020-022-03134-4
R.R. Sharma, M.J. Chandy, S.D. Lad, Diencephalic syndrome of emaciation in an adult associated with a suprasellar craniopharyngioma: a case report. Br. J. Neurosurg. 4, 77–80 (1990)
doi: 10.3109/02688699009000687
pubmed: 2334532
M.A. Nuijts, N. Veldhuis, I. Stegeman, H.M. Van Santen, G.L. Porro, S.M. Imhof, A.Y.N. Schouten-van Meeteren, Visual functions in children with craniopharyngioma at diagnosis: A systematic review. PLoS. One. (2020). https://doi.org/10.1371/journal.pone.0240016